Rx-to-OTC switch consumer self-diagnosis is "concern" of National Consumers League.
This article was originally published in The Tan Sheet
Executive Summary
NATIONAL CONSUMERS LEAGUE "CONCERNED" WITH RELIANCE ON SELF-DIAGNOSIS for some Rx-to-OTC switches, NCL President Linda Golodner commented at a May 12 conference on Rx-to-OTC switches in Washington, D.C. sponsored by International Business Communications. NCL, she said, is "concerned about the implications" of self-diagnosis of conditions, such as pink eye or stomach pain, that may be more serious than they appear and may not be appropriately treated with OTCs.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning